What Does Galectin Therapeutics Do?

Total employees41
HeadquartersNorcross
Founded2000

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to improve the lives of patients with chronic liver disease, fibrosis, and cancer. Their lead drug candidate, belapectin (GR-MD-02), is a complex carbohydrate drug that targets galectin-3, a protein implicated in the pathogenesis of fibrotic diseases and cancer. The company is primarily focused on advancing belapectin for the treatment of non-alcoholic steatohepatitis (NASH) with cirrhosis and in combination with immunotherapy for various cancers. Galectin Therapeutics aims to address significant unmet medical needs through its innovative scientific approach.

Where Is Galectin Therapeutics's Headquarters?

HQ Function

Serves as the primary corporate office and hub for research and development oversight, clinical trial management, and administrative operations.

Notable Features:

The facility comprises office space for administrative, clinical, and regulatory staff, supporting the company's focused drug development programs. Specific architectural highlights for this type of office suite are not publicly emphasized.

Work Culture:

As a clinical-stage biotech, the culture is likely focused, results-driven, and collaborative, emphasizing scientific rigor and innovation in a lean operational environment. Employees are typically dedicated to advancing medical science for patient benefit.

HQ Significance:

The headquarters is central to strategic decision-making, managing pivotal clinical trials for its lead candidate belapectin, and engaging with regulatory bodies, the scientific community, and investors.

Values Reflected in HQ: The HQ's operations reflect values such as scientific innovation, patient-centricity, and efficient resource management, crucial for a clinical-stage biopharmaceutical company.

Location:

Galectin Therapeutics's global presence is primarily manifested through its clinical trial operations. These trials, particularly for its lead candidate belapectin, often involve sites in multiple countries across North America, Europe, and potentially other regions to ensure diverse patient enrollment and gather comprehensive data. While its corporate and R&D management is centralized in the U.S., the company collaborates with international researchers, contract research organizations (CROs), and regulatory agencies as part of its global drug development strategy.

Street Address:

4960 Peachtree Industrial Blvd., Suite 240

City:

Norcross

State/Province:

Georgia

Country:

USA

Where Else Does Galectin Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Galectin Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Galectin Therapeutics? Meet the Executive Team

As of April 2025, Galectin Therapeutics' leadership includes:

Joel Lewis - Chief Executive Officer
Jack W. Callicutt, CPA - Chief Financial Officer, Treasurer and Corporate Secretary
Pol F. Boudes, M.D. - Consultant Chief Medical Officer

Who's Investing in Galectin Therapeutics?

Galectin Therapeutics has been backed by several prominent investors over the years, including:

Richard E. Uihlein
The Vanguard Group, Inc.
BlackRock Fund Advisors
Geode Capital Management, LLC
State Street Global Advisors

What Leadership Changes Has Galectin Therapeutics Seen Recently?

Hire1
Exits0

In the last 12 months (calculated from mid-2023 to mid-2024), Galectin Therapeutics solidified its financial leadership by appointing Jack W. Callicutt as permanent Chief Financial Officer in December 2023, transitioning him from his prior interim role. No other C-level executive departures or new C-level hires from outside the company have been publicly announced during this specific period.

New Appointments:

Jack W. Callicutt, Jack W. Callicutt appointed as permanent Chief Financial Officer, previously served as Interim CFO.

What Technology (Tech Stack) Is Used byGalectin Therapeutics?

Discover the tools Galectin Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Galectin Therapeutics Email Formats and Examples

Galectin Therapeutics primarily uses the email format combining the employee's first initial followed by their last name at the galectintherapeutics.com domain. This is a common pattern for corporate communications.

[first_initial][last]@galectintherapeutics.com

Format

jdoe@galectintherapeutics.com

Example

70%

Success rate

What's the Latest News About Galectin Therapeutics?

GlobeNewswireMay 7, 2024

Galectin Therapeutics to Report Financial Results for the First Quarter Ended March 31, 2024 and Provide Business Update on May 14, 2024

Galectin Therapeutics announced it will release its first-quarter 2024 financial results and host a conference call on May 14, 2024, to discuss the results and provide a business update on its programs....more

GlobeNewswireMarch 12, 2024

Galectin Therapeutics Reports Financial Results for the Year Ended December 31, 2023 and Provides Business Update

Galectin Therapeutics announced its financial results for the full year 2023 and provided a comprehensive business update, including progress on its NAVIGATE study of belapectin in NASH cirrhosis....more

GlobeNewswireJanuary 23, 2024

Galectin Therapeutics Provides Update on NAVIGATE Study, its Phase 2b/3 Clinical Trial of Belapectin in NASH Cirrhosis

Galectin Therapeutics provided an update on its NAVIGATE Study, detailing advancements in patient screening, site activation for its pivotal trial of belapectin, and reiterated its expectation for an interim analysis in Q4 2024....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Galectin Therapeutics, are just a search away.